CN101284087A - Medicinal composition for curing lumbar disease - Google Patents
Medicinal composition for curing lumbar disease Download PDFInfo
- Publication number
- CN101284087A CN101284087A CNA2008100182502A CN200810018250A CN101284087A CN 101284087 A CN101284087 A CN 101284087A CN A2008100182502 A CNA2008100182502 A CN A2008100182502A CN 200810018250 A CN200810018250 A CN 200810018250A CN 101284087 A CN101284087 A CN 101284087A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- lumbar
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a pharmaceutical composition for treating lumbar diseases. The composition contains milk vetch, cassia twig, peony, notopterygium root, Chinese Angelica, jambolan, pinellia tuber, Chinese quince, poria, trifoliate orange fruit, root of red rooted salvia, antler, ceiba, himalayan teasel root, cibot rhizome, Chinese milkwort, frankincense, myrrh, ground beetle, nux vomica, roasted pangolin, showy eriolaena bark, parasite scurrula, radix cyathulae, nutgrass galingale rhizome, corydalis tuber, liquorice, medlar, earthworm, homalomena rhizome, etc. Clinical tests prove that the composition is effective in treating lumbar intervertebral disc protrusion, lumbar hyperplasia, cervical vertebra hyperplasia, narrow lumbar canal, lumbar spondylolisthesis, lumbar muscle strain, fracture, bone sprain, traumatic arthralgia, etc., with good effect.
Description
Technical field
The invention belongs to technical field of Chinese medicines, relate to a kind of Chinese medicine composition, relate in particular to a kind of pharmaceutical composition for the treatment of lumbar spondylosis.
Background technology
Lumbar spondylosis is a kind of commonly encountered diseases, frequently-occurring disease.Mostly be prolapse of lumbar intervertebral disc clinically, prolapse of lumbar intervertebral disc be a kind of be that cardinal symptom, comparatively common spinal column are sick and wounded with waist, buttocks, skelalgia, and often control or malpractice because of early stage mistake, increase the weight of and cause intervertebral disc chondroclasis, vertebral pulp to give prominence to, cause serious waist buttocks skelalgia or lower limb sciatica, bring very big misery to the patient.
The treatment lumbar spondylosis has two kinds of operation and non-operations, and operative treatment only limits to the obvious spinal cord of fraction, nerve root and the impaired patient of vertebral artery, and most of lumbar spondylosis needs to treat by non-operative treatment.The traditional method of Chinese traditional treatment lumbar spondylosis is a massage therapy, and its course of treatment is long, and it is slow to take effect, and if be very dangerous with massage and rotation above neck, lumbar vertebra physiology dynamics scope.
Summary of the invention
The purpose of this invention is to provide a kind of pharmaceutical composition for the treatment of cervical spondylosis.
The compositions of pharmaceutical composition of the present invention is prepared into acceptable preparation on the materia medica by following bulk drugs:
6～10 parts of 6～10 portions of Rhizoma Et Radix Notopterygiis of 6～10 portions of Radix Paeoniaes of 10～15 parts of Ramulus Cinnamomi of the Radix Astragali
Beg 8～13 parts of 5～8 parts of TIEJIAOLI of 6～10 parts of Rhizoma Pinelliaes of 10～15 parts of Oleum Linderae in vain
10～15 parts in 8～13 parts of Cornu Cervi Pantotrichums of 5～8 parts of Radix Salviae Miltiorrhizaes of 6～10 parts of Fructus Aurantiis of Poria
6～10 parts of 8～13 parts of Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) of 5～8 parts of Rhizoma Cibotii of 6～10 parts of Radix Dipsacis of kapok
8～13 parts bitter real 10～15 parts of 5～8 parts of eupolyphaga of 5～8 parts of Myrrhas of Olibanum
Process 0～5 part of 0～15 part of Scorpio of 0～10 part of Herba Taxilli of 10～15 parts of Cortex torricelliae tiliifoliaes of Squama Manis
0～10 part of 0～10 part of Bombyx Batryticatus of 0～10 part of Rhizoma Corydalis of river cattle sunset 6～10 portions of Rhizoma Cyperis
6～8 parts of 8～13 parts of Rhizoma Homalomenaes of 0～10 part of Pheretima of 1～6 portion of Fructus Lycii of Radix Glycyrrhizae.
In the aforementioned pharmaceutical compositions, Ramulus Cinnamomi, Radix Paeoniae, Radix Glycyrrhizae are with the sour and sweet drugs can transforme into YIN harmonizing yingfen and weifen; Rhizoma Cyperi, Rhizoma Corydalis, eupolyphaga, Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae), Radix Salviae Miltiorrhizae is begged, Oleum Linderae in vain, and Radix Dipsaci is with circulation of qi promoting, promoting the circulation of blood, blood circulation promoting and blood stasis dispelling; The Rhizoma Et Radix Notopterygii dehumidifying is induced sweat; Cortex torricelliae tiliifoliae, Scorpio, Bombyx Batryticatus, TIEJIAOLI, Olibanum, Myrrha, river Niu Xi, Pheretima are with channels sootheing and network vessel quickening; The Rhizoma Pinelliae, Poria, Fructus Aurantii eliminating phlegm and removing dampness; The Radix Astragali, kapok, Rhizoma Cibotii, Cornu Cervi Pantotrichum, Rhizoma Homalomenae, Herba Taxilli, Fructus Lycii are to transfer tonifying kidney-yin, and be vigorous to reach QI and blood; Bitter real, process Squama Manis with hard masses softening and resolving, detumescence.
The function of medicine of the present invention: blood circulation promoting and blood stasis dispelling, channels sootheing and network vessel quickening, invigorating the liver and kidney, expelling wind and removing dampness.
Cure mainly: prolapse of lumbar intervertebral disc, hyperosteogeny, hyperosteogeny, lumbar spinal stenosis, lumbar spondylolisthesis, lumbar muscle strain, fracture, bone sprain, wound sequela and wound bone joint pain for a long time.
The effect of traditional Chinese medicine composition for treating cervical spondylosis of the present invention can be illustrated by following clinical trial:
1, case is selected: prolapse of lumbar intervertebral disc patient's 50 examples, hyperosteogeny patient 120 examples, hyperosteogeny patient 50 examples, lumbar spinal stenosis 40 examples, lumbar spondylolisthesis 90 examples, lumbar muscle strain 60 examples, fracture, bone sprain patient 50, wound sequela and wound bone joint pain 20 examples for a long time.
2, Therapeutic Method: powder, one time 3 gram, 2 times on the one, course of treatment of two weeks, one to two course of treatment of state of an illness the lighter, the heavier person of the state of an illness needs three to four courses of treatment.
3, curative effect is calmed down standard
3.1 recovery from illness: Signs recovers normal, follows up a case by regular visits to and does not have repeatedly in 3 months.
3.2 produce effects: Signs obviously has improvement, and slight illness obviously alleviates.
3.3 effectively: Signs makes moderate progress can operate as normal.
3.4 invalid: Signs is without any improvement.
4, therapeutic outcome:
4.1 prolapse of lumbar intervertebral disc patient
Prolapse of lumbar intervertebral disc patient's 50 examples, wherein cure rate 72%, and obvious effective rate 18% is effective 8%, inefficiency 2%.
4.2 hyperosteogeny patient
Hyperosteogeny patient 120 examples, wherein cure rate 84%, and obvious effective rate 12% is effective 4%, inefficiency 0%.
4.3 lumbar spinal stenosis
Lumbar spinal stenosis patient 40 examples, wherein cure rate 62%, and obvious effective rate 28% is effective 8%, inefficiency 2%.
4.4 lumbar spondylolisthesis
Lumbar spondylolisthesis 90 examples, wherein cure rate 78%, and obvious effective rate 18% is effective 4%, inefficiency 0%.
4.5 lumbar muscle strain
Lumbar muscle strain 60 examples, wherein cure rate 92%, and obvious effective rate 6% is effective 2%, inefficiency 0%.
4.6 fracture, bone sprain patient
Fracture, bone sprain patient 50, wherein cure rate 68%, and obvious effective rate 28% is effective 4%, inefficiency 0%.
4.7 long wound sequela and wound bone joint pain patient.
For a long time wound sequela and wound bone joint pain 20 examples, wherein cure rate 14%, and obvious effective rate 42% is effective 32%, inefficiency 12%.
Clinical observation finds that also medicine of the present invention has good therapeutic effect to the hyperosteogeny disease.
The specific embodiment
The preparation of embodiment 1, capsule
Prescription: by weight
6 parts of 6 portions of Rhizoma Et Radix Notopterygiis of 6 portions of Radix Paeoniaes of 10 parts of Ramulus Cinnamomi of the Radix Astragali
Beg 8 parts of 5 parts of TIEJIAOLI of 6 parts of Rhizoma Pinelliaes of 10 parts of Oleum Linderae in vain
10 parts in 8 parts of Cornu Cervi Pantotrichums of 5 parts of Radix Salviae Miltiorrhizaes of 6 parts of Fructus Aurantiis of Poria
6 parts of 8 parts of Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) of 5 parts of Rhizoma Cibotii of 6 parts of Radix Dipsacis of kapok
8 parts bitter real 10 parts of 5 parts of eupolyphaga of 5 parts of Myrrhas of Olibanum
Process 3 parts of 5 parts of Scorpio of 3 parts of Herba Taxillis of 10 parts of Cortex torricelliae tiliifoliaes of Squama Manis
5 parts of 5 parts of Bombyx Batryticatus of 8 parts of Rhizoma Corydalis of river cattle sunset 6 portions of Rhizoma Cyperis
6 parts of 8 parts of Rhizoma Homalomenaes of 7 parts of Pheretimas of 3 portions of Fructus Lyciis of Radix Glycyrrhizae.
Technology: the conventional adjuvant for preparing capsule by pharmacy of Chinese materia medica becomes capsule with prepared.
The preparation of embodiment 2, powder
Prescription: by weight
10 parts of 10 portions of Rhizoma Et Radix Notopterygiis of 10 portions of Radix Paeoniaes of 15 parts of Ramulus Cinnamomi of the Radix Astragali
Beg 13 parts of 8 parts of TIEJIAOLI of 10 parts of Rhizoma Pinelliaes of 15 parts of Oleum Linderae in vain
15 parts in 10 parts of Cornu Cervi Pantotrichums of 8 parts of Radix Salviae Miltiorrhizaes of 10 parts of Fructus Aurantiis of Poria
10 parts of 13 parts of Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) of 6 parts of Rhizoma Cibotii of 10 parts of Radix Dipsacis of kapok
13 parts bitter real 15 parts of 8 parts of eupolyphaga of 8 parts of Myrrhas of Olibanum
Process 10 parts of 0～15 part of Scorpio of 15 parts of Herba Taxillis of Squama Manis, 5 parts of river cattle sunset
1～6 part in 5 parts of Radix Glycyrrhizaes of 5 parts of Bombyx Batryticatus of 10 parts of Rhizoma Corydalis of Rhizoma Cyperi
8 parts of 10 parts of Rhizoma Homalomenaes of 8 parts of Pheretimas of Fructus Lycii.
Technology: the common process for preparing powder by pharmacy of Chinese materia medica is prepared into powder.
The preparation of embodiment 3, electuary
Prescription: by weight
8 parts of 8 portions of Rhizoma Et Radix Notopterygiis of 8 portions of Radix Paeoniaes of 10 parts of Ramulus Cinnamomi of the Radix Astragali
Beg 8 parts of 8 parts of TIEJIAOLI of 10 parts of Rhizoma Pinelliaes of 12 parts of Oleum Linderae in vain
12 parts in 8 parts of Cornu Cervi Pantotrichums of 5 parts of Radix Salviae Miltiorrhizaes of 8 parts of Fructus Aurantiis of Poria
6 parts of 8 parts of Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) of 8 parts of Rhizoma Cibotii of 8 parts of Radix Dipsacis of kapok
8 parts bitter real 12 parts of 8 parts of eupolyphaga of 8 parts of Myrrhas of Olibanum
Process 2 parts of river cattle sunset of 12 parts of Scorpio of Squama Manis, 8 parts of 8 portions of Rhizoma Cyperis
8 parts of 6 portions of Fructus Lyciis of 8 parts of Radix Glycyrrhizaes of 8 parts of Bombyx Batryticatus of Rhizoma Corydalis
8 parts of 8 parts of Rhizoma Homalomenaes of Pheretima.
Technology: the conventional adjuvant for preparing electuary by pharmacy of Chinese materia medica becomes electuary with prepared.
The preparation of embodiment 4, pill
Prescription: by weight
8 parts of 8 portions of Rhizoma Et Radix Notopterygiis of 8 portions of Radix Paeoniaes of 12 parts of Ramulus Cinnamomi of the Radix Astragali
Beg 10 parts of 8 parts of TIEJIAOLI of 10 parts of Rhizoma Pinelliaes of 12 parts of Oleum Linderae in vain
12 parts in 8 parts of Cornu Cervi Pantotrichums of 8 parts of Radix Salviae Miltiorrhizaes of 10 parts of Fructus Aurantiis of Poria
10 parts of 13 parts of Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) of 8 parts of Rhizoma Cibotii of 10 parts of Radix Dipsacis of kapok
8 parts bitter real 10 parts of 5 parts of eupolyphaga of 5 parts of Myrrhas of Olibanum
Process 10 parts of 5 parts of Pheretimas of Squama Manis 10 parts of river cattle sunset, 8 parts of Radix Glycyrrhizaes
6 parts of Rhizoma Homalomenaes.
Technology: the conventional adjuvant for preparing pill by pharmacy of Chinese materia medica becomes pill with prepared.
The preparation of embodiment 5, tablet
Prescription: by weight
60 parts of 6 portions of Rhizoma Et Radix Notopterygiis of 6 portions of Radix Paeoniaes of 10 parts of Ramulus Cinnamomi of the Radix Astragali
Beg 8 parts of 5 parts of TIEJIAOLI of 10 parts of Rhizoma Pinelliaes of 15 parts of Oleum Linderae in vain
10 parts in 13 parts of Cornu Cervi Pantotrichums of 8 parts of Radix Salviae Miltiorrhizaes of 10 parts of Fructus Aurantiis of Poria
6 parts of 8 parts of Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) of 5 parts of Rhizoma Cibotii of 6 parts of Radix Dipsacis of kapok
13 parts bitter real 10 parts of 8 parts of eupolyphaga of 8 parts of Myrrhas of Olibanum
Process 10 parts of 3 parts of Scorpio of 10 parts of Cortex torricelliae tiliifoliaes of Squama Manis, 4 parts of river cattle sunset
5 parts of 6 portions of Fructus Lyciis of 8 parts of Radix Glycyrrhizaes of 8 parts of Rhizoma Corydalis of Rhizoma Cyperi
8 parts of 10 parts of Rhizoma Homalomenaes of Pheretima.
Technology: the conventional adjuvant for preparing tablet by pharmacy of Chinese materia medica becomes tablet with prepared.
Claims (2)
1, a kind of pharmaceutical composition for the treatment of cervical spondylosis is prepared from by following bulk drugs:
6～10 parts of 6～10 portions of Rhizoma Et Radix Notopterygiis of 6～10 portions of Radix Paeoniaes of 10～15 parts of Ramulus Cinnamomi of the Radix Astragali
Beg 8～13 parts of 5～8 parts of TIEJIAOLI of 6～10 parts of Rhizoma Pinelliaes of 10～15 parts of Oleum Linderae in vain
10～15 parts in 8～13 parts of Cornu Cervi Pantotrichums of 5～8 parts of Radix Salviae Miltiorrhizaes of 6～10 parts of Fructus Aurantiis of Poria
6～10 parts of 8～13 parts of Radix Stephaniae Sinicae (Radix Stephaniae Dielsianae) of 5～8 parts of Rhizoma Cibotii of 6～10 parts of Radix Dipsacis of kapok
8～13 parts bitter real 10～15 parts of 5～8 parts of eupolyphaga of 5～8 parts of Myrrhas of Olibanum
Process 0～5 part of 0～15 part of Scorpio of 0～10 part of Herba Taxilli of 10～15 parts of Cortex torricelliae tiliifoliaes of Squama Manis
0～10 part of 0～10 part of Bombyx Batryticatus of 0～10 part of Rhizoma Corydalis of river cattle sunset 6～10 portions of Rhizoma Cyperis
6～8 parts of 8～13 parts of Rhizoma Homalomenaes of 0～10 part of Pheretima of 1～6 portion of Fructus Lycii of Radix Glycyrrhizae.
2, treat the pharmaceutical composition of cervical spondylosis according to claim 1, it is characterized in that: it is characterized in that: adopt the common process and the adjuvant of pharmaceutics, be prepared into acceptable preparation on the materia medica.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100182502A CN101284087B (en) | 2008-05-09 | 2008-05-09 | Medicinal composition for curing lumbar disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100182502A CN101284087B (en) | 2008-05-09 | 2008-05-09 | Medicinal composition for curing lumbar disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101284087A true CN101284087A (en) | 2008-10-15 |
| CN101284087B CN101284087B (en) | 2010-12-22 |
Family
ID=40056641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100182502A Expired - Fee Related CN101284087B (en) | 2008-05-09 | 2008-05-09 | Medicinal composition for curing lumbar disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101284087B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103007036A (en) * | 2012-12-28 | 2013-04-03 | 葛风晓 | Chinese herba preparation for treating vertebral compression fractures |
| CN107184648A (en) * | 2017-06-02 | 2017-09-22 | 广州智润生物制药科技有限公司 | It is a kind of to treat patch of protrusion of lumber intervertebral disc and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1141127C (en) * | 2001-08-09 | 2004-03-10 | 杨双喜 | Medicine for treating protrusion of cervical and lumbar intervertebral disc |
| CN100515477C (en) * | 2003-12-22 | 2009-07-22 | 高化育 | Chinese medicine decoction for treating prolapse of lumber intercertebtral disc |
-
2008
- 2008-05-09 CN CN2008100182502A patent/CN101284087B/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103007036A (en) * | 2012-12-28 | 2013-04-03 | 葛风晓 | Chinese herba preparation for treating vertebral compression fractures |
| CN103007036B (en) * | 2012-12-28 | 2014-02-26 | 葛风晓 | Chinese herba preparation for treating vertebral compression fractures |
| CN107184648A (en) * | 2017-06-02 | 2017-09-22 | 广州智润生物制药科技有限公司 | It is a kind of to treat patch of protrusion of lumber intervertebral disc and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101284087B (en) | 2010-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100402066C (en) | Plaster for treating rheumatism and osteoarthrosis | |
| CN100361704C (en) | Medicated wine for treating rheumatosis and osteoarthropathy | |
| CN101095845A (en) | Century health preserving magical wine | |
| CN101485836A (en) | Oral capsule for treating neck, waist and leg pain diseases and preparation method thereof | |
| CN103006951B (en) | Chinese medicinal composition for treating cervical spondylosis and lumbar spondylosis | |
| CN101766775A (en) | Medicine for treating lumbar disc herniation and osteoproliferation | |
| CN102283921A (en) | Prescription drug for curing jugular and lumbar herniated disk | |
| CN1970045B (en) | Externally applied Chinese medicine for treating cervical and lumbar spondylosis | |
| CN102048900A (en) | Traditional Chinese medicine preparation for treating lumbar intervertebral disc protrusion | |
| CN103316141A (en) | Traditional Chinese medicine composition for treating cervical spondylosis | |
| CN101658657B (en) | Drug for treating chronic cholecystitis | |
| CN101112537A (en) | Chinese traditional medicine preparations for treating hyperosteogeny disease | |
| CN104013769A (en) | Traditional Chinese medicine oral solution for treating osteoporosis | |
| CN104000933A (en) | Traditional Chinese medicine oral liquid for treating osteoproliferation | |
| CN103316296B (en) | Traditional Chinese medicine composition for treating hyperostosis | |
| CN101284087B (en) | Medicinal composition for curing lumbar disease | |
| CN1079029C (en) | Medical capsule for treating bone rheumatism and preparing process | |
| CN104383166A (en) | Medicine for treating rheumatic lumbocrural pains and preparation method thereof | |
| CN103800840A (en) | Oral traditional Chinese medicine solution for treating cervical spondylosis | |
| CN103784824A (en) | Chinese herbal preparation for treating lumbar disc herniation and rheumatoid | |
| CN102579672A (en) | Medicament for treating bone hyperplasia and lumbar disc herniation | |
| CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
| CN102406870A (en) | Medicament for treating rheumatic arthralgia | |
| CN1129439C (en) | Hyperosteogeny-treating capsule | |
| CN102552461B (en) | Medicinal moxa roll for treating knee osteoarthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101222 Termination date: 20170509 |